| 2023-09-15 |
Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers |
Cancer Research. 2023 Sep 15;83(18):2993-3000. |
 |
| 2023-03 |
ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression |
Cancer Research. 2023 Mar 15;83(6):830-844. |
|
| 2021-06-22 |
A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells [Erratum:Frontiers in Oncology. 2021 May 31;11:Article number 638311.] |
Frontiers in Oncology. 2021 Jun 22;11:Article number 718849. |
|
| 2021-05-31 |
A novel invadopodia-specific marker for invasive and pro-metastatic cancer stem cells |
Frontiers in Oncology. 2021 May 31;11:Article number 638311. |
|
| 2021-05 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer |
Gastric Cancer. 2021 May;24(3):624-639. |
|
| 2021-05 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 May;24(3):624-639.] |
Gastric Cancer. 2021 May;24(3):640-641. |
|
| 2020-03-10 |
Dishevelled 1-regulated superpotent cancer stem cells mediate wnt heterogeneity and tumor progression in hepatocellular carcinoma |
Stem Cell Reports. 2020 Mar 10;14(3):462-477. |
|
| 2020-02 |
The multifaceted role of mesenchymal stem cells in cancer |
Seminars in Cancer Biology. 2020 Feb;60:225-237. |
|
| 2020-01 |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study |
European Journal of Cancer. 2020 Jan;124:123-130. |
|
| 2019-12 |
The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis |
Journal of Pathology. 2019 Dec;249(4):498-508. |
|
| 2019-11-13 |
Histone demethylase KDM4C stimulates the proliferation of prostate cancer cells via activation of AKT and c-Myc |
Cancers. 2019 Nov 13;11(11):Article number 1785. |
|
| 2019-07 |
Targeting the interplay between cancer fibroblasts, mesenchymal stem cells, and cancer stem cells in desmoplastic cancers |
Frontiers in Oncology. 2019 Jul;9:Article number 688. |
|
| 2019-05-17 |
Next viable routes to targeting pancreatic cancer stemness: Learning from clinical setbacks |
Journal of Clinical Medicine. 2019 May 17;8(5):Article number 702. |
|
| 2019-02 |
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling |
Oncogene. 2019 Feb;38(8):1340-1353. |
|
| 2019-02 |
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.] |
Oncogene. 2019 Feb;38(8):1354. |
|
| 2018-12 |
ACTL6a promotes metastasis and predicts poor prognosis of prostate cancer via regulation of YAP and cancer stemness |
Cancer Science. 2018 Dec;109(Suppl. 2):244. |
|
| 2018-11 |
Targeting PTX3 can prevent drug-resistant cancer progression |
Protein Science. 2018 Nov;27(Suppl. 1):24. |
|
| 2018-10 |
Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study |
Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 736P. |
|
| 2017-11 |
Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma |
Biochemical and Biophysical Research Communications. 2017 Nov;493(1):14-19. |
|
| 2017-05 |
Metronomic chemotherapy: Direct targeting of cancer cells after all? |
Trends in Cancer. 2017 May;3(5):319-325. |
|
| 2016-12 |
Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells |
Journal of Experimental Medicine. 2016 Dec;213 (13):2967-2988. |
|
| 2016-12 |
NCoR2 mediates death-resistance and mechano-regulation of glioblastoma multiforme |
Molecular Biology of the Cell. 2016 Dec;27:Meeting Abstract P1160. |
|
| 2016-02 |
Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC) |
Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369. |
|
| 2015-11 |
Proteomics profiling of epigenetic proteins during acinar morphogenesis to identify prostate cancer prognostic markers |
Annals of Oncology. 2015 Nov;26:vii106-vii151. |
|
| 2015-09 |
Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers |
Oncotarget. 2015 Sep;6(27):23987-24001. |
|
